Developmental biology offers the key to finding solutions for paediatric cancer, metastasis, and regeneration Blog Post

From today and until Wednesday,  around 20 speakers from around the world and 150 participants will debate cutting-edge research into plasticity and cell migration—two key aspects in paediatric cancer, metastasis, and regeneration, at the Institut d’Estudis Catalans on the occasion of the 18th Barcelona Biomed Conference, an event organised by the Institute for Research in Biomedicine (IRB Barcelona) –based at PCB– with the support of the BBVA Foundation.

 

Laboratorios Ordesa enters the pediatric dermatology market Blog Post

Laboratorios Ordesa, with a history of over 70 leading child nutrition, has now entered the dermatology market with the marketing of Pediatopic, a new product line for the care of atopic skin in children. Since 2007, Ordesa has had a R&D&I center at  Parc Científic de Barcelona (PCB) from where the company actively takes part in clinical trials and national and international research programs to enhance the health and quality of life of individuals, especially during the maternal and child stage of life. 

 

UL Acquires AWS Truepower to expand global renewable energy portfolio Blog Post

UL (Underwriters Laboratories), a global safety science leader, announces the acquisition of  AWS Truepower, a leading energy engineering services and advisory firm. This achievement expands UL’s global renewable energy portfolio by strengthening full lifecycle solutions for wind and solar energy sectors. AWS Truepower operates in Europe and Latin America through AWS Truepower SLU, a spanish company located at the Barcelona Scientific Park (PCB).

 

Half of patients with type 2 diabetes do not have their disease under control Blog Post

Therapeutic compliance in type 2 diabetes mellitus (DM2) is crucial. However, only 30%-50% of patients receiving oral antidiabetics, and not even 25% of those receiving insulin adhere to their treatment regimen1. The worst compliers are younger patients who, moreover, are at greater risk of developing cardiovascular complications. This was the claim of the specialists who attended Diabento, a symposium organized by Esteve, of more than 450 physicians from all around Spain who analyzed current and future challenges in DM2 from a multidisciplinary perspective. Esteve and PCB have been working closely since 2003.

 

Broad participation of Barcelona Science Park at BioSpain 2016 Blog Post

The Bilbao Exhibition Center (BEC) in Barakaldo (Bizkaia) will host  BioSpain 2016, the 8th edition of the eighth edition of this biennial event of biotechnology, the largest in Europe with permanent headquarters in one country and the fifth in the world ranking by number of partnering meetings. The event, to be held from 28 to 30 September, will bring together more than 2,000 attendees, 855 companies and nearly 50 investors- and will feature the participation of the Barcelona Science Park (PCB) and a large number of companies and entities of the PCB Community.

 

IRB Barcelona and IBMB-CSIC have been presented with funding from AECC for cancer research Blog Post

Jelena Urosevic and Carles Barceló, postdoctoral fellows at the Institute for Research in Biomedicine (IRB Barcelona), and Elisa Martí Gorostiza, researcher at the Institut de Biologia Molecular de Barcelona (IBMB-CSIC) –both located at the Barcelona Science Park–  have officially been presented with funding over 5 years from the Asociación Española Contra el Cáncer (AECC) for their respective research projects on cancer.

 

The genetic history of Aboriginal Australians Blog Post

The CNAG, based at Barcelona Science Park, participates in a study that analyses the genome of the Aboriginal Australian population that will help to understand how modern humans left the African continent. The findings of this study are published in Nature. The CNAG reseacher Òscar Lao, leader of the Population Genomics team, is first co-author of this work and contributed to the study analysing and interpreting the sub-populations of Aboriginal Australians. The debate over whether anatomically modern humans left the African continent in one or several waves is very intense in this Nature edition.

 

The 16th edition of ‘Recerca en Societat’ program starts up at PCB Blog Post

Today, on 19 September 2016, the Barcelona Science Park (PCB) opens the enrollment period to participate in the experimental workshops ‘Fes recerca!’ (Do Research!) and ‘Descobreix la recerca!’ (Discover Research!), which gives the start to the 16th edition of ‘Recerca in Societat’ (Research in Society). This proposal of PCB to bring science to the public and encourage vocations among young people includes over 120  activities, involving annually about 6,000 people.

 

IRB Barcelona presents the “Alumni of Excellence Award” to David Vilchez Blog Post

Today the Institute for Research in Biomedicine (IRB Barcelonahas presented David Vilchez, group leader at the CECAD-Cluster of Excellence in Cologne, Germany, with a commemorative certificate naming him as the first winner of the Alumni of Excellence Award. Vilchez obtained his PhD from IRB Barcelona in 2008, and three years ago he began his own group in Germany, where he has been awarded an ERC Starting Grant.